. Author manuscript; available in PMC: 2015 Apr 6.

Published in final edited form as: Clin Rheumatol. 2010 Apr;29(4):363–367. doi: 10.1007/s10067-009-1314-9

Table 3.

United States (US) versus United Kingdom (UK) in Medication Use at Baseline

Medication Type	US N (%)	UK N (%)	p-value
Biologics	50 (47)	9 (16)	<0.001
Cytotoxic DMARDs	67 (63)	40 (73)	0.23
Non-Cytotoxic DMARDs	31 (29)	13 (24)	0.45
Steroids	42 (40)	12 (22)	0.02
Cox-2 Inhibitors	14 (13)	1 (2)	0.02
NSAIDs	23 (22)	33 (60)	<0.001

DMARDs=Disease Modifying Anti-Rheumatic Drugs

NSAIDs=Non-Steroidal Anti-Inflammatory Drugs

Some patients take medications from more than one medication type